Sexual Rehabilitation and Penile Pain Associated with Intracavernous Alprostadil after Radical Prostatectomy

Journal of Sexual Medicine

Volumn 8, Issue 2, 2011, Pages 575-582

  Yiou, René ^a   Cunin, Patrick ^a   De La Taille, Alexandre ^a   Salomon, Laurent ^a   Binhas, Michele ^a   Lingombet, Odile ^a   Paul, Murielle ^a   Abbou, Claude ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Alprostadil; Erectile dysfunction; Radical prostatectomy; Sexual pain; Sexual rehabilitation

Indexed keywords

PROSTAGLANDIN E1; PROSTAVASIN;

ADULT; ARTICLE; CLINICAL TRIAL; CORRELATION ANALYSIS; DRUG DOSE INCREASE; ERECTION HARDNESS SCORE; FOLLOW UP; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN ASSESSMENT; PATIENT SATISFACTION; PENILE PAIN; PENIS ERECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATECTOMY; RATING SCALE; REHABILITATION CARE; SEXUAL INTERCOURSE; SEXUAL REHABILITATION; SEXUAL SATISFACTION; TREATMENT DURATION;

EID: 79551471853     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.02002.x     Document Type: Article

References (38)

1. Salomon L, Anastasiadis AG, Katz R, De La Taille A, Saint F, Vordos D, Cicco A, Hoznek A, Chopin D, Abbou CC. Urinary continence and erectile function: A prospective evaluation of functional results after radical laparoscopic prostatectomy. Eur Urol 2002;42:338-43.
2. Giuliano F, Amar E, Chevallier D, Montaigne O, Joubert JM, Chartier-Kastler E. How urologists manage erectile dysfunction after radical prostatectomy: A national survey (REPAIR) by the French urological association. J Sex Med 2008;5:448-57.
3. Montorsi F, Briganti A, Salonia A, Rigatti P, Burnett AL. Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol 2004;45:123-33.
4. Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M, Stief C. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008;54:924-31.
5. Zagaja GP, Mhoon DA, Aikens JE, Brendler CB. Sildenafil in the treatment of erectile dysfunction after radical prostatectomy. Urology 2000;56:631-4.
6. Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L, Rigatti P, Pizzini G, Miani A. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: Results of a prospective, randomized trial. J Urol 1997;158:1408-10.
7. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2005;2:532-40 (Discussion 40-2).
8. Mulhall JP, Bella AJ, Briganti A, McCullough A, Brock G. Erectile function rehabilitation in the radical prostatectomy patient. J Sex Med 2010;7:1687-98.
9. Burnett AL, Aus G, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus S, Liebert M, Moul JW, Tangen C, Thrasher JB, Thompson I. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol 2007;178:597-601.
10. Mulhall JP. Defining and reporting erectile function outcomes after radical prostatectomy: Challenges and misconceptions. J Urol 2009;181:462-71.
11. Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT. Factors predicting recovery of erections after radical prostatectomy. J Urol 2000;164:1929-34.
12. Gontero P, Fontana F, Bagnasacco A, Panella M, Kocjancic E, Pretti G, Frea B. Is there an optimal time for intracavernous prostaglandin E1 rehabilitation following nonnerve sparing radical prostatectomy? Results from a hemodynamic prospective study. J Urol 2003;169:2166-9.
13. Descazeaud A, Debre B, Flam TA. Age difference between patient and partner is a predictive factor of potency rate following radical prostatectomy. J Urol 2006;176:2594-8 (Discussion 98).
14. Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. N Engl J Med 1996;334:873-7.
15. Porst H. The rationale for prostaglandin E1 in erectile failure: A survey of worldwide experience. J Urol 1996;155:802-15.
16. Mulhall JP, Parker M, Waters BW, Flanigan R. The timing of penile rehabilitation after bilateral nerve-sparing radical prostatectomy affects the recovery of erectile function. BJU Int 2010;105:37-41. Epub 2009 Jul 31.
17. Porst H, Buvat J, Meuleman E, Michal V, Wagner G. Intracavernous Alprostadil Alfadex-an effective and well tolerated treatment for erectile dysfunction. Results of a long-term European study. Int J Impot Res 1998;10:225-31.
18. Kim SC, Lee SW, Seo KK. Characteristics of pain following intracavernous injection of prostaglandin E1. J Korean Med Sci 1997;12:327-31.
19. Weiss JN, Badlani GH, Ravalli R, Brettschneider N. Reasons for high drop-out rate with self-injection therapy for impotence. Int J Impot Res 1994;6:171-4.
20. de la Taille A, Delmas V, Amar E, Boccon-Gibod L. Reasons of dropout from short- and long-term self-injection therapy for impotence. Eur Urol 1999;35:312-7.
21. Goeman L, Salomon L, La De Taille A, Vordos D, Hoznek A, Yiou R, Abbou CC. Long-term functional and oncological results after retroperitoneal laparoscopic prostatectomy according to a prospective evaluation of 550 patients. World J Urol 2006;24:281-8.
22. Mulhall J, Althof SE, Brock GB, Goldstein I, Junemann KP, Kirby M. Erectile dysfunction: Monitoring response to treatment in clinical practice-recommendations of an international study panel. J Sex Med 2007;4:448-64.
23. Mulhall JP, Goldstein I, Bushmakin AG, Cappelleri JC, Hvidsten K. Validation of the erection hardness score. J Sex Med 2007;4:1626-34.
24. Jensen MP, Miller L, Fisher LD. Assessment of pain during medical procedures: A comparison of three scales. Clin J Pain 1998;14:343-9.
25. Paul SM, Zelman DC, Smith M, Miaskowski C. Categorizing the severity of cancer pain: Further exploration of the establishment of cutpoints. Pain 2005;113:37-44.
26. Katz R, Salomon L, Hoznek A, de la Taille A, Vordos D, Cicco A, Chopin D, Abbou CC. Patient reported sexual function following laparoscopic radical prostatectomy. J Urol 2002;168:2078-82.
27. Brock G, Tu LM, Linet OI. Return of spontaneous erection during long-term intracavernosal alprostadil (Caverject) treatment. Urology 2001;57:536-41.
28. Titta M, Tavolini IM, Moro FD, Cisternino A, Bassi P. Sexual counseling improved erectile rehabilitation after non-nerve-sparing radical retropubic prostatectomy or cystectomy-Results of a randomized prospective study. J Sex Med 2006;3:267-73.
29. Sadovsky R, Basson R, Krychman M, Morales AM, Schover L, Wang R, Incrocci L. Cancer and sexual problems. J Sex Med 2010;7:349-73.
30. Schramek P, Plas EG, Hubner WA, Pfluger H. Intracavernous injection of prostaglandin E1 plus procaine in the treatment of erectile dysfunction. J Urol 1994;152:1108-10.
31. Albaugh J, Ferrans CE. Patient-reported pain with initial intracavernosal injection. J Sex Med 2009;6:513-9.
32. Grossman SA, Sheidler VR, Swedeen K, Mucenski J, Piantadosi S. Correlation of patient and caregiver ratings of cancer pain. J Pain Symptom Manage 1991;6:53-7.
33. Diatchenko L, Nackley AG, Slade GD, Bhalang K, Belfer I, Max MB, Goldman D, Maixner W. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006;125:216-24.
34. Teloken P, Valenzuela R, Parker M, Mulhall J. The correlation between erectile function and patient satisfaction. J Sex Med 2007;4:472-6.
35. Droupy S, Giuliano F, Costa P. [Erectile rehabilitation after radical prostatectomy]. Prog Urol 2009;19(4 suppl):S193-7.
36. Glickman L, Godoy G, Lepor H. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy. J Urol 2009;181:731-5.
37. Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004;171:771-4.
38. Salonia A, Gallina A, Zanni G, Briganti A, Deho F, Sacca A, Suardi N, Barbieri L, Guazzoni G, Rigatti P, Montorsi F. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008;53:564-70.